Madhuri Gaddam, Nagaraju Ravouru
email@example.com , firstname.lastname@example.org
Madhuri Gaddam1, Nagaraju Ravouru2
1Assistant Professor, Department of Pharmaceutics, Rao’s College of Pharmacy, Chemudugunta (P.O.), Venkatachalam (M), Nellore, Andhra Pradesh. 524320.
2Professor, Institute of Pharmaceutical Technology, Sri Padmavati Mahila Viswavidhalayam, Tirupati – 517502.
Volume - 14,
Issue - 1,
Year - 2021
Introduction: Omeprazole, a proton-pump inhibitor used in peptic ulcers, gastro-oesophageal-reflux disorder, Zollinger-Ellison syndrome and in H.pylori infections. The omeprazole is unstable at acidic pH, undergoes degradation in stomach. To prevent the degradation in stomach, dosage forms are supplied as enteric-coated tablets or granules encapsulated in gelatin capsules. The efficiency of such dosage forms depends upon the extent of coating, solubility of coating material, type of dosage forms; in addition this it is insoluble in water, having poor bioavailability. To overcome these major drawbacks of omeprazole, an novel technique: co-crystallization was attempted, to produce a stable, enhancement in solubility and improved micromeritic properties of omeprazole. Co-crystals consists of API and a stoichiometric amount of a pharmaceutically acceptable co-crystal former. Pharmaceutical Co-crystals are non-ionic supramolecular complexes and can be used to address physical property issues such as solubility, stability and bioavailability in pharmaceutical development without changing the chemical composition of the API. Co-crystal is a crystalline entity formed by two different or more molecular entities where the intermolecular interactions are weak forces like hydrogen bonding and p- p stacking. Materials and methods: As omeprazole is unstable in acidic pH, very hygroscopic character, photosensitive and thermolebility in nature, Anti solvent addition method was used for preparation of crystals. Poly Vinyl Pyrrolidone is taken as co-former, magnesium chloride and sodium bicarbonate as basic substances. Further prepared crystals were characterized by Powder X-ray Diffractometer (PXRD), Differential scanning colorimeter (DSC), Fourier Transformation Infra-red Spectroscopy (FTIR).Moreover they were studied for melting point determination, flow property studies (micromeritic properties),dissolution studies, solubility test and stability tests. Results and discussion: FTIR revealed that there is no formation of hydrogen bonding between drug and co-former; hence it states that co-crystals are not formed, but XRD and DSC states that there is a formation of some physical interaction, partial crystalline and amorphous form which is a new crystal lattice. Conclusion: Formed crystals produce moderate improvement in micromeritic properties, solubility, stability and dissolution behaviour of drug. Thus physicochemical properties of omeprazole were improved via crystal engineering technique – co-crystallization.
Cite this article:
Madhuri Gaddam, Nagaraju Ravouru. A Crystal Engineering design to enhance the Solubility, Dissolution, Stability and Micromeritic properties of Omeprazole via Co-crystallization Techniques. Research J. Pharm. and Tech. 2021; 14(1):356-362. doi: 10.5958/0974-360X.2021.00065.2
Madhuri Gaddam, Nagaraju Ravouru. A Crystal Engineering design to enhance the Solubility, Dissolution, Stability and Micromeritic properties of Omeprazole via Co-crystallization Techniques. Research J. Pharm. and Tech. 2021; 14(1):356-362. doi: 10.5958/0974-360X.2021.00065.2 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-65
1. Rama Nargund and A R Kulkarni, Synthesis, characterization and antiulcer study of ph-sensitive microspheres. scholars research library. Der Pharmacia Lettre,2011, 3(6):82-89
2. Nanjwade and Meenaxi M. Maste. New trends in the co-crystallization of active pharmaceutical ingredients. Journal of Applied Pharmaceutical Science 01 (08); 2011: 01-05.
3. Kushal Shah, Sheetal Borhade, Vaishali Londhe. Utilization of co-crystallization for solubility enhancement of a poorly soluble antiretroviral drug – Ritonavir. International Journal of Pharmacy and Pharmaceutical Sciences Volume 6, Issue 2, 2014
4. Upadhyay N, Shukla T P, Mathur A, Manmohana, Pharmaceutical co-crystal: An emerging approach to improve physical property. International Journal of Pharmaceutical Sciences Review and Research, Volume 8, Issue 1, May – June 2011; Article-026
5. Higuchi T, Connors K. Phase-solubility techniques. Advances in Analytical Chemistry and Instrumentation, 4, 1965, 117-212
6. Renu Chadha, Anupam Saini, Poonam Arora, Somnath Chanda. Co-crystals of efavirenz with selected coformers: preparation and characterization. International Journal of Pharmacy and Pharmaceutical Sciences Vol 4, Issue 2, 2012
7. Altaf Ahmad Najar and Yasser Azim. Pharmaceutical Co-Crystals: A New Paradigm of Crystal Engineering. Journal of the Indian Institute of Science VOL 94:1 Jan.–Mar. 2014 journal.iisc.ernet.in
8. Sulbha R. Fukte, Milind P. Wagh, Shilpi Rawat. Co-former selection: An important tool in co-crystal formation. International Journal of Pharmacy and Pharmaceutical Sciences Issue- 0975-1491 Volume 6, Issue 7, 2014
9. Tanvee Patole and Ashwini Deshpande. Co-crystallization-a technique for solubility enhancement. International Journal of Pharmaceutical Sciences and Research, 2014; vol. 5(9): 3566-3576
10. M K-Jafari, Luis P, G M. Walker, and D M. Croker. Creating Co-crystals: A Review of Pharmaceutical Co-crystal Preparation Routes and Applications. Crystal Growth Desgin-2018
11. Mandava V. Basaveswara Rao, B.C.K. Reddy, T. Srinivasa Rao. Dissolution test for omeprazole pellets 8.5% (high dissolution): optimization and statistical analysis. RJC Rasayan J. Chem vol.1, no.3 (2008), 618-619.
12. S. Shahid Mohammed, G. Venkatarajagopal Reddy, K. Viswaganga Pranush., Comparison of solubility improvement of cefixime and omeprazole magnesium by solid dispersion and slugging method. International Journal of Research in Pharmaceutical and Nano Sciences. 3(1), 2014, 50 - 60.
13. Y. Divya Bharathi and V.B. Rajesh. Enhancement solubility of lovastatin drug by using liquid-solid technique. World Journal of Pharmaceutical Research Volume 6, Issue 17, 567-587.
14. Sonawane Aravind R, Rawat Swati S, Janolkar Nandkishor N. Insights of Dosage form Design: Polymorphs and Co-crystals. Asian Journal of Biomedical and Pharmaceutical Sciences; 03 (27); 2013; 1-8.
15. Sirisha Mittapally and Arifa Banu. Formulation and evaluation of omeprazole nanoparticles by using natural polymers. The Pharma Innovation Journal 2016; 5(10): 111-117